INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 64 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $61,000 | +306.7% | 51,580 | +191.7% | 0.00% | – |
Q1 2020 | $15,000 | -11.8% | 17,685 | +1.4% | 0.00% | – |
Q4 2019 | $17,000 | -34.6% | 17,435 | -30.9% | 0.00% | – |
Q3 2019 | $26,000 | -55.2% | 25,244 | -21.5% | 0.00% | – |
Q2 2019 | $58,000 | -31.8% | 32,169 | -28.9% | 0.00% | -100.0% |
Q1 2019 | $85,000 | +142.9% | 45,232 | +54.2% | 0.00% | – |
Q4 2018 | $35,000 | -67.3% | 29,324 | -25.8% | 0.00% | -100.0% |
Q3 2018 | $107,000 | +148.8% | 39,524 | +73.9% | 0.00% | – |
Q2 2018 | $43,000 | -95.6% | 22,724 | -96.4% | 0.00% | -100.0% |
Q2 2017 | $983,000 | -54.4% | 625,865 | -6.3% | 0.01% | -57.1% |
Q1 2017 | $2,158,000 | +122.9% | 668,040 | -6.8% | 0.01% | +100.0% |
Q4 2016 | $968,000 | -10.7% | 717,075 | +3.2% | 0.01% | -12.5% |
Q3 2016 | $1,084,000 | +25.2% | 694,875 | +6.7% | 0.01% | +33.3% |
Q2 2016 | $866,000 | -74.0% | 651,275 | +3.2% | 0.01% | -76.9% |
Q1 2016 | $3,327,000 | -27.7% | 631,275 | +7.7% | 0.03% | -31.6% |
Q4 2015 | $4,601,000 | +13.1% | 586,150 | +21.8% | 0.04% | +15.2% |
Q3 2015 | $4,068,000 | +477.0% | 481,375 | +647.5% | 0.03% | +450.0% |
Q2 2015 | $705,000 | +4.0% | 64,400 | +32.8% | 0.01% | 0.0% |
Q1 2015 | $678,000 | -2.6% | 48,500 | +17.7% | 0.01% | 0.0% |
Q4 2014 | $696,000 | – | 41,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,354,963 | $38,132,000 | 1.80% |
Orbimed Advisors | 4,520,800 | $73,201,000 | 1.55% |
QVT Financial LP | 1,326,610 | $21,480,000 | 1.44% |
BB BIOTECH AG | 1,089,828 | $17,646,000 | 1.27% |
Meditor Group Ltd | 250,000 | $4,048,000 | 0.55% |
Perimeter Capital Partners, LLC | 159,915 | $2,589,000 | 0.50% |
EMERALD MUTUAL FUND ADVISERS TRUST | 156,808 | $2,539,000 | 0.43% |
Broadfin Capital, LLC | 117,172 | $1,897,000 | 0.37% |
OXFORD ASSET MANAGEMENT LLP | 811,331 | $13,184,000 | 0.36% |
Baker Brothers Advisors | 1,016,433 | $16,458,000 | 0.33% |